Use of digital breast tomosynthesis varies across the country and among practices, but is most often used clinically.
Digital breast tomosynthesis (DBT) is not used consistently throughout the country, according to a study published in the Journal of the American College of Radiology.
Researchers from the University of Denver in Colorado created an online survey to assess how DBT was used and the criteria used by physicians to offer DBT to patients. The survey, which included questions about the availability of DBT at the participant's practice, whether DBT was used for clinical care or research, clinical decision rules guiding patient selection for DBT, costs associated with DBT, plans to obtain DBT, and breast imaging practice characteristics, was sent to 670 members of the Society of Breast Imaging.
The response rate to the survey was 37 percent. Two hundred physicians (30 percent) reported using DBT, with 89 percent of these using DBT clinically. DBT was used most often in academic practices, in practices that had more than three breast imagers and in practices that had seven or more mammography units.
“Criteria used to select patients to undergo DBT varied, with 107 (68.2 percent) using exam type (screening versus diagnostic), 25 (15.9 percent) using mammographic density, and 25 (15.9 percent) using breast cancer risk,” the authors wrote. Looking at costs, the fees for DBT ranged from $25 to $250. Among nonusers, 62.3 percent planned to obtain DBT.
The researchers found a geographic difference in DBT use. Practices in the northeast and west were more likely to use DBT:
The researchers concluded that use of DBT varied considerably throughout the country. “Clinical guidelines would assist practices in deciding whether to adopt DBT and in standardizing which patients should receive DBT,” they wrote.
[[{"type":"media","view_mode":"media_crop","fid":"25191","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_7094825934618","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2271","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 1px; border-style: solid; height: 423px; width: 500px; float: right;","title":"Image courtesy of the Journal of the American College of Radiology. © 2014 American College of Radiology. ","typeof":"foaf:Image"}}]]
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.